Secondary Logo

Journal Logo

You can read the full text of this article if you:

Ovid Member Institutional Access
ORIGINAL STUDIES

Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children

SÁEZ-LLORENS, XAVIER MD; VIOLARI, AVYI MD; DEETZ, CARL O. BA; RODE, RICHARD A. PhD; GOMEZ, PERRY FACP; HANDELSMAN, EDWARD MD; PELTON, STEPHEN MD; RAMILO, OCTAVIO MD; CAHN, PEDRO MD; CHADWICK, ELLEN MD; ALLEN, UPTON FRCPC; ARPADI, STEPHEN MD; CASTREJÓN, MARIA MERCEDES MD; HEUSER, RENEE S. BS; KEMPF, DALE J. PhD; BERTZ, RICHARD J. PhD; HSU, ANN F. PhD; BERNSTEIN, BARRY MD; RENZ, CHERYL L. MD; SUN, EUGENE MD

Author Information
The Pediatric Infectious Disease Journal: March 2003 - Volume 22 - Issue 3 - p 216-223
doi: 10.1097/01.inf.0000055061.97567.34
  • Buy

Abstract

© 2003 Lippincott Williams & Wilkins, Inc.